ProShare Advisors’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $601K | Sell |
8,011
-663
| -8% | -$42.6K | ﹤0.01% | 986 |
|
|
2026
Q1 | $489K | Sell |
8,674
-2,015
| -19% | -$131K | ﹤0.01% | 1081 |
|
|
2025
Q4 | $857K | Buy |
10,689
+397
| +4% | +$26.7K | ﹤0.01% | 873 |
|
|
2025
Q3 | $502K | Sell |
10,292
-2,274
| -18% | -$141K | ﹤0.01% | 1102 |
|
|
2025
Q2 | $938K | Sell |
12,566
-318
| -2% | -$21.1K | ﹤0.01% | 841 |
|
|
2025
Q1 | $819K | Sell |
12,884
-3,602
| -22% | -$245K | ﹤0.01% | 867 |
|
|
2024
Q4 | $1.29M | Buy |
16,486
+4,771
| +41% | +$383K | ﹤0.01% | 821 |
|
|
2024
Q3 | $942K | Buy |
11,715
+2,599
| +29% | +$210K | ﹤0.01% | 836 |
|
|
2024
Q2 | $754K | Sell |
9,116
-2,374
| -21% | -$209K | ﹤0.01% | 809 |
|
|
2024
Q1 | $981K | Buy |
11,490
+516
| +5% | +$40.5K | ﹤0.01% | 792 |
|
|
2023
Q4 | $938K | Buy |
10,974
+1,718
| +19% | +$149K | ﹤0.01% | 769 |
|
|
2023
Q3 | $829K | Sell |
9,256
-215
| -2% | -$19.2K | ﹤0.01% | 760 |
|
|
2023
Q2 | $806K | Buy |
9,471
+570
| +6% | +$48.2K | ﹤0.01% | 772 |
|
|
2023
Q1 | $737K | Sell |
8,901
-1,518
| -15% | -$123K | ﹤0.01% | 786 |
|
|
2022
Q4 | $819K | Buy |
10,419
+1,200
| +13% | +$96.5K | ﹤0.01% | 783 |
|
|
2022
Q3 | $681K | Sell |
9,219
-134
| -1% | -$9.62K | ﹤0.01% | 810 |
|
|
2022
Q2 | $610K | Sell |
9,353
-5,194
| -36% | -$307K | ﹤0.01% | 877 |
|
|
2022
Q1 | $920K | Sell |
14,547
-2,369
| -14% | -$129K | ﹤0.01% | 956 |
|
|
2021
Q4 | $897K | Buy |
16,916
+5,724
| +51% | +$349K | ﹤0.01% | 1090 |
|
|
2021
Q3 | $790K | Sell |
11,192
-7,587
| -40% | -$479K | ﹤0.01% | 991 |
|
|
2021
Q2 | $1.25M | Buy |
18,779
+13,914
| +286% | +$985K | ﹤0.01% | 907 |
|
|
2021
Q1 | $540K | Sell |
4,865
-24
| -0.5% | -$2.97K | ﹤0.01% | 1388 |
|
|
2020
Q4 | $581K | Buy |
4,889
+590
| +14% | +$63.5K | ﹤0.01% | 1166 |
|
|
2020
Q3 | $375K | Buy |
4,299
+151
| +4% | +$13.2K | ﹤0.01% | 1062 |
|
|
2020
Q2 | $371K | Sell |
4,148
-1,582
| -28% | -$160K | ﹤0.01% | 1105 |
|
|
2020
Q1 | $571K | Sell |
5,730
-6,719
| -54% | -$729K | ﹤0.01% | 708 |
|
|
2019
Q4 | $1.43M | Buy |
12,449
+1,600
| +15% | +$194K | 0.01% | 695 |
|
|
2019
Q3 | $1.37M | Buy |
10,849
+100
| +0.9% | +$12.7K | 0.01% | 673 |
|
|
2019
Q2 | $1.29M | Sell |
10,749
-1,085
| -9% | -$107K | 0.01% | 682 |
|
|
2019
Q1 | $1.03M | Buy |
11,834
+1,412
| +14% | +$128K | 0.01% | 746 |
|
|
2018
Q4 | $1.04M | Sell |
10,422
-2,029
| -16% | -$213K | 0.01% | 694 |
|
|
2018
Q3 | $1.43M | Sell |
12,451
-313
| -2% | -$32.4K | 0.01% | 684 |
|
|
2018
Q2 | $1.15M | Buy |
12,764
+2,855
| +29% | +$241K | 0.01% | 782 |
|
|
2018
Q1 | $725K | Sell |
9,909
-1,023
| -9% | -$70.2K | ﹤0.01% | 952 |
|
|
2017
Q4 | $635K | Buy |
10,932
+5,049
| +86% | +$266K | ﹤0.01% | 1017 |
|
|
2017
Q3 | $264K | Sell |
5,883
-624
| -10% | -$25.9K | ﹤0.01% | 1188 |
|
|
2017
Q2 | $257K | Sell |
6,507
-1,700
| -21% | -$69.8K | ﹤0.01% | 1238 |
|
|
2017
Q1 | $333K | Sell |
8,207
-1,902
| -19% | -$74.3K | ﹤0.01% | 1191 |
|
|
2016
Q4 | $406K | Buy |
10,109
+3,283
| +48% | +$124K | ﹤0.01% | 1189 |
|
|
2016
Q3 | $247K | Sell |
6,826
-2,268
| -25% | -$77.9K | ﹤0.01% | 1237 |
|
|
2016
Q2 | $264K | Buy |
9,094
+500
| +6% | +$15.1K | ﹤0.01% | 1266 |
|
|
2016
Q1 | $301K | Sell |
8,594
-2,088
| -20% | -$67.4K | ﹤0.01% | 1203 |
|
|
2015
Q4 | $344K | Buy |
10,682
+2,942
| +38% | +$95.4K | ﹤0.01% | 1229 |
|
|
2015
Q3 | $250K | Sell |
7,740
-2,536
| -25% | -$95.4K | ﹤0.01% | 1215 |
|
|
2015
Q2 | $425K | Sell |
10,276
-3,838
| -27% | -$162K | 0.01% | 1163 |
|
|
2015
Q1 | $634K | Sell |
14,114
-808
| -5% | -$33.8K | 0.01% | 1070 |
|
|
2014
Q4 | $558K | Sell |
14,922
-8,503
| -36% | -$311K | 0.01% | 1142 |
|
|
2014
Q3 | $818K | Sell |
23,425
-5,750
| -20% | -$205K | 0.01% | 1145 |
|
|
2014
Q2 | $1.03M | Sell |
29,175
-25,517
| -47% | -$852K | 0.01% | 1145 |
|
|
2014
Q1 | $1.78M | Buy |
54,692
+48,698
| +812% | +$1.86M | 0.02% | 835 |
|
|
2013
Q4 | $253K | Sell |
5,994
-28,729
| -83% | -$1.18M | ﹤0.01% | 1209 |
|
|
2013
Q3 | $1.39M | Sell |
34,723
-1,488
| -4% | -$62.4K | 0.03% | 634 |
|
|
2013
Q2 | $1.5M | Buy |
+36,211
| New | +$1.47M | 0.03% | 607 |
|
Other funds holding HAE
AI
ProShare Advisors's HAE Position: Q2 2026 in Review
ProShare Advisors reduced its Haemonetics (HAE) stake by 7.6% in Q2 2026, selling an estimated $42.6K and leaving 8,011 shares worth $601K. The position accounts for ﹤0.01% of the portfolio, ranked #986.
ProShare Advisors first reported a position in HAE in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.78M in Q1 2014. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- ProShare Advisors held 8,011 shares of Haemonetics worth $601K as of Q2 2026.
- ProShare Advisors sold 663 Haemonetics shares in Q2 2026, an estimated $42.6K.
- Haemonetics made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #986 holding.
- ProShare Advisors first reported a position in Haemonetics in Q2 2013 and has held it in 53 quarters since.
- ProShare Advisors's Haemonetics position peaked at $1.78M in Q1 2014.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.